Collegium Pharmaceutical, Inc · Brief

Next report

4 days

Nov 5 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

3 of 8≥ implied

Nov 7 '24±9.4%▼−7.35%×0.78

Feb 27 '25±13.8%▲+2.22%×0.16

May 8 '25±10.4%▲+5.94%×0.57

Aug 7 '25±10.3%▲+10.72%×1.04

Q3 FY25±9.4%▲+13.42%×1.43

Q1 FY26±7.7%▼−3.34%×0.44

May 7 '26±12.6%▲+7.72%×0.61

Q2 FY26±12.2%▼−18.55%×1.52

quarterimplied−20%0+20%realized×

Q2 FY26±12.2%▼−18.55%×1.52

May '26±12.6%▲+7.72%×0.61

Q1 FY26±7.7%▼−3.34%×0.44

Q3 FY25±9.4%▲+13.42%×1.43

Aug '25±10.3%▲+10.72%×1.04

May '25±10.4%▲+5.94%×0.57

2 older reports

Feb '25±13.8%▲+2.22%×0.16

Nov '24±9.4%▼−7.35%×0.78

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2

278managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+6.14%change in shares held by the ten largest reporting managers in the latest quarter13F · Jun 30 '26

Bear2 of 4

5 of 8recent reports where the move came in under the options implied rangeEarnings history

3tracked funds holding COLLN-PORT · Aug 31 '26

AI captions · Sep 16 '26once per report · top 2 per case

COLL report session

No linked exposure.

Oct 22impliedImplied move: ±20.1% into Nov 5 earnings (Oct 22 close).Source

Oct 198-KMaterial agreement: settlement agreement with Grünenthal GmbH ("Grünenthal") (terminated).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.